Engaged. Knowledge. Application
RECORDING

Recorded: Thursday, September 17th, 2009
11:00 a.m. EST-12:00 noon -Eastern Standard Time-United States
INSTRUCTOR: Celeste Rose, RQAP-GLP, President/GLP Subject Matter Expert, RoseTECH Consulting, Inc.
➢Purchase the Recording in the enKap Store
The low $139.00 Webinar Recording fee includes:
➢PowerPoint Presentation (PDF)
➢Webinar recording
➢Frequently Asked Questions and Answers Subject Matter Document
➢Free Membership in enKap's FDA Compliance learning community - simply fill out a profile
Webinar Content
All experimental data generated in a GLP study, including observations of unanticipated responses, are required to be accurately recorded and verified. Proper documentation of deviations and events is crucial to the reconstructability of a GLP study and the quality and compliance of the study report. Documentation of protocol and SOP deviations and unexpected events can be problematic if not handled properly, and can impact the integrity of the study. This session defines amendments, deviations and unforeseen circumstances, similarities and differences, and presents strategies for the prevention and/or minimization of the potential for the occurrence of unnecessary deviations, as well as proper documentation of the inevitable.
Effective tactics to enhancing proper GLP-compliant documentation and handling of deviations are discussed and includes approaches to reducing the stigma of deviations, so as to foster good communication between study personnel and study director when deviations and unusual events do occur.
➢GLP Studies – Welcome to the Real World!
➢Defining Amendment, Deviation and Unforeseen Circumstances
➢Ideal World vs. Real World – what can go wrong: Procedures, Test systems, Test articles, Equipment, Documentation, Schedules, Samples
➢Protocol Amendments: Intentional changes, Proper documentations, Requirements, Benefits – Use it as a “Tool”
➢ Deviations: Types of Deviations - protocol, SOP, test methods, regulations; How/when do they occur, Causes
➢ Unforeseen Circumstances: Recognizing when to document, When do they occur
➢Deviations and Unforeseen Circumstances: Proper documentation, Requirements, Benefits – Use it as a “Tool”
➢Documentation: What to write, When/how to document, Review and approval – what do the regulations require, Corrective actions, Assessment of impact on study integrity, Formats
➢Aspirations: Prevent the “avoidable” pitfalls, Minimize the “potential” for deviations, Prepare for the “inevitable unknown”
➢Plan for the Best/Prepare for the Worst: Well written procedures, Avoiding Pitfalls, Examples of Do’s and Don’ts, When All Else Fails – Document!
QUESTIONS AND ANSWERS
There will be a 15-minute question and answer period for attendees to submit questions. If we are unable to answer your question due to time constraints, our instructor Celeste Rose will provide an email response after the webinar concludes.
WHAT ATTENDEES WILL LEARN IN THIS WEBINAR
In this webinar, you will review or learn the following:
➢Basic GLP requirements pertaining to amendment, deviations and events
➢GLP roles and responsibilities
➢How to indentify and raise awareness of when deviations occur
➢Effective documentation of amendments, deviations and events
➢How to prevent, minimize and prepare for deviations
➢Real-life examples and resolutions
➢How to objectively address excursions and remove the stigma barriers.
WHO SHOULD ATTEND
This webinar is an ideal presentation for those individuals in your organization involved in the following functions:
➢Study Director
➢Principal Investigators/Contributing Scientists
➢Study Personnel
➢Test Facility Management/Test Site Management
➢Quality Assurance
➢Document Control
➢Sponsors
About Your Instructor
Celeste A. Rose, RQAP-GLP, president of RoseTECH Consulting, has a bachelor’s degree in Chemistry and is certified by the Society of Quality Assurance (SQA) as a GLP Registered Quality Assurance Professional (RQAP-GLP). Ms. Rose has 25 years GLP experience and 10 years experience as a Study Director. She has a broad base of expertise in EPA, FDA and OECD Good Laboratory Practice, including study direction/study conduct, protocol/report writing and documentation, technical writing, SOPs writing and review, archiving procedures, data, in-study and facility audits and regulatory and technical training. Ms. Rose has over seven years experience as President of RoseTECH Consulting, Inc. as a consultant in the areas of GLP and Quality Assurance.
Join the U.S. FDA and Major Pharma and Device Manufacturers who attend our events; Pfizer, Merck, Johnson & Johnson, AstraZeneca, Medtronic, Boston Scientific, Alcon, Schering-Plough, Roche, Bristol Myers Squibb, Becton Dickinson and more...
***SCHEDULE***
GLP LIVE Training Workshops - (click here for complete brochure)
Two GLP Workshops in Two Locations
1. The Brass Tacks of GLP: Practical Understanding of the Fundamentals As Never Before Explained
2. Writing Effective GLP Docments
March 9-10, 2010 San Diego
March 11-12, 2010 San Francisco by a GLP Subject Matter Expert
Medical Device Software Validation LIVE Training Workshops - (click here for complete brochure)
Two Workshops in Two Locations
1. Medical Device Software Validation: System Definition and Requirements: Incorporating Effectiveness and Compliance in Software Design
2. Implementing Critical Processes for Effectively Supporting Medical Device Software Validation Programs
March 24-25, 2010 Iselin, NJ
May 19-20, 2010 Waltham, MA by Boston Scientific
CAPA LIVE Training Workshops - (click here for complete brochure)
Two Workshops
1. CAPA: Effective System Management - One Industry Professional Shares His Expertise
2.Supplier-Related CAPA: Conducting Effective Root Cause Investigations
April 20-21, 2010 Boston/Waltham, MA
by a CAPA Subject Matter Expert
GMP LIVE Training Workshop: Master Production Batch Records - (click here for complete brochure)
Effective Generation and Control of Master Production Batch Records (MPBR)
April 22, 2010 Boston/Waltham, MA by a GMP Subject Matter Expert
May 12-13, 2010 Hilton Woodbridge-Iselin, NJ by a GMP Subject Matter Expert
To View Previously Recorded Webinars Click Here
Special 21 CFR Part 11 Recording Package - Click Here for More Details
Recent Webinar TESTIMONIALS:
"It was the perfect presentation for my audience. Over the last year, since I started retraining all my frequent fliers, I have gone over or flagged for action every concern in that presentation. I had people in the audience that needed a final re-enforcement. I believe every "hot-topic" in Change Control was covered". - Anuja Rajbhandari, Change Control Specialist - AstraZeneca - CLICK HERE TO VIEW THE WEBINAR ON CHANGE CONTROL
"Enjoyed it. It was like the trainer has worked at our facility!!" - Carol S. Spicer, Director, Quality, Training and Support Services - Bridge Laboratories - CLICK HERE TO VIEW THE WEBINAR ON GLP DEVIATIONS

U.S. Toll Free: 877-823-4GXP
Outside the U.S. +1-561-795-2785
Fax: +1-561-798-8138e-mail: info@enkap.com
1480 Royal Palm Beach Blvd.,Suite A, Royal Palm Beach, FL 33411, U.S.

enKap Terms and Conditions
All sales are final
Legal Disclaimer
This product and any of its enclosures, attachments or appendices, references to online information, conferences or preparations of materials in a variety of formats are created to provide you with accurate and authorative information concerning the subject matter covered. However, this product and any other ancillary items disseminated in connec-
tion with same are not necessarily prepared by a person licensed to practice law in a particular jurisdiction.
enKap, Inc. is not engaged in rendering legal advice, and this product is not a substitute for the advice of an attorney. If you require legal or other expert advice, you should seek
the services of a competent attorney or other professional.
enKap, Inc. necessarily is not, cannot and will not be liable for any claims, damages, or regulatory legal proceedings initiated as a consequence of you, the customer, modifying,
altering, adding to or deleting portions of any product initially provided by enKap, Inc.
Once any original document provided by enKap, Inc. to you, whether in print or electronic format, has been manipulated or customized by you, then the responsibility for the
document’s accuracy, correctness, and compliance are solely yours.
If any action, claim for damages, or regulatory proceedings is commenced against enKap, Inc. as a consequence of your alteration or modification, etc. of the document templates
or other originally provided materials, then and in that event, you agree to indemnify enKap, Inc. for such claims, and for any attorney’s fees expended by enKap, Inc. in connec-
tion with defense of same.
© copyright 2010 enKap
© 2010 Created by enKap